DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Yada K, Nogami K, Kasai R. , et al.
A novel hemostatic monitoring system convertible to FVIII activity based on non-activated ROTEM (NATEM) for hemophilia A patients during emicizumab prophylaxis.
60th Annual Meeting of the American Society of Hematology (ASH) December 1–4, 2018 ; San Diego, CA
We do not assume any responsibility for the contents of the web pages of other providers.